For Immediate Release
Chicago, IL –December 23, 2019 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: JPMorgan Chase (JPM - Free Report) , Boeing (BA - Free Report) , NVIDIA (NVDA - Free Report) , AstraZeneca (AZN - Free Report) and GlaxoSmithKline (GSK - Free Report) .
Here are highlights from Friday’s Analyst Blog:
Top Analyst Reports for JPMorgan, Boeing and NVIDIA
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including JPMorgan Chase, Boeing and NVIDIA. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today’s research reports here >>>
JPMorgan’s shares have outperformed the Zacks Major Regional Banks industry year to date (+41.6% vs. +34.2%). The Zacks analyst believes that decent loan demand, acquisition of InstaMed, opening of new branches and focus on strengthening credit card business will aid financials.
JPMorgan's shares have outperformed the industry over the past six months. The company has an impressive earnings surprise history. The bank has surpassed the Zacks Consensus Estimate in three of the trailing four quarters. Also, enhanced capital deployment plan reflects strong balance sheet position and will enhance shareholder value.
However, the Fed’s accommodative policy will likely hamper top line growth to some extent. The company’s significant dependence on capital markets revenues makes us apprehensive, given the several geopolitical concerns. Further, the company is likely to face challenges in expanding mortgage operations. Hence, these matters are expected to hamper fee revenue growth.
(You can read the full research report on JPMorgan here >>>)
Shares of Boeing have lost 12% in the past three months against the Zacks Aerospace & Defense industry’s decline of 4.1%. The Zacks analyst believes that the company’s proposed joint venture with Embraer is expected to strengthen its commercial business significantly. The proposed partnership is expected to be accretive to Boeing’s earnings at the start of 2020 and generate estimated annual pre-tax cost synergies of approximately $150 million by the third year.
Boeing remains the largest aircraft manufacturer globally in terms of revenues, orders and deliveries, and one of the major aerospace and defense contractors. Its proposed joint venture with Embraer is expected to strengthen its commercial business significantly.
However, its commercial business has suffering due to lower 737 deliveries, following its 737 MAX product line's grounding and subsequent costs associated with it. Consequently, its revenues, earnings and cash flow position were affected significantly.
(You can read the full research report on Boeing here >>>)
NVIDIA's shares have gained 57.5% over the past six months against the Zacks General Semiconductor industry's rise of 28.9%. The Zacks analyst believes that the company is benefiting from strong growth in GeForce desktop and notebook GPUs, which is boosting gaming revenues. Solid momentum of its real-time ray tracing technology is also a positive.
NVIDIA delivered better-than-expected third-quarter fiscal 2020 results. Increase in Hyperscale demand is a tailwind for Data Center business as well. Growing adoption in the inference market is an upside too. Further, the solid uptake of AI-based smart cockpit infotainment solutions is a boon.
Additionally, strength across mobile workstation products is aiding Professional Visualization revenues. However, the company’s bleak guidance for the fourth quarter due to seasonality is a concern. Management expects strong sequential growth in Data Center to be offset by a seasonal decline in GeForce notebook GPUs and SoC modules for gaming platforms.
(You can read the full research report on NVIDIA here >>>)
Other noteworthy reports we are featuring today include AstraZeneca and GlaxoSmithKline.
More Stock News: This Is Bigger than the iPhone!
It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.
Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020.
Click here for the 6 trades >>
Zacks Investment Research
800-767-3771 ext. 9339
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.